
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19903079
[patent_doc_number] => 12280063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
[patent_app_type] => utility
[patent_app_number] => 17/253781
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 83
[patent_no_of_words] => 28077
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253781 | Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease | Jun 19, 2019 | Issued |
Array
(
[id] => 16954887
[patent_doc_number] => 11058714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Administration of synergistic amounts of modified citrus pectin and honokiol to treat inflammation and anti-oxidant needs
[patent_app_type] => utility
[patent_app_number] => 16/439563
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6956
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439563
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/439563 | Administration of synergistic amounts of modified citrus pectin and honokiol to treat inflammation and anti-oxidant needs | Jun 11, 2019 | Issued |
Array
(
[id] => 18327763
[patent_doc_number] => 11632974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Nutritional composition for improving cell membranes
[patent_app_type] => utility
[patent_app_number] => 16/435141
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14104
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16435141
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/435141 | Nutritional composition for improving cell membranes | Jun 6, 2019 | Issued |
Array
(
[id] => 16671286
[patent_doc_number] => 20210060049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => PHYTOCHEMICAL-ANTIBIOTIC COMBINATION FOR THE TREATMENT OF A BACTERIAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/046164
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046164
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046164 | Phytochemical-antibiotic combination for the treatment of a bacterial infection | May 30, 2019 | Issued |
Array
(
[id] => 19389397
[patent_doc_number] => 20240279267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => LIPID-MODIFIED NUCLEIC ACID COMPOUNDS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/058562
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058562 | LIPID-MODIFIED NUCLEIC ACID COMPOUNDS AND METHODS | May 29, 2019 | Pending |
Array
(
[id] => 15209603
[patent_doc_number] => 20190367488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => NOVEL BENZODIAZEPINE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/425237
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16425237
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/425237 | Benzodiazepine derivatives and uses thereof | May 28, 2019 | Issued |
Array
(
[id] => 16930943
[patent_doc_number] => 20210196832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => TARGETED NANOPREPARATION OF MANNOSE, AND PREPARATION THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/058533
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -63
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058533 | TARGETED NANOPREPARATION OF MANNOSE, AND PREPARATION THEREFOR AND APPLICATION THEREOF | May 21, 2019 | Abandoned |
Array
(
[id] => 17242623
[patent_doc_number] => 20210362366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => GREEN WOOD ADHESIVE
[patent_app_type] => utility
[patent_app_number] => 17/056635
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056635 | Green wood adhesive | May 20, 2019 | Issued |
Array
(
[id] => 17109973
[patent_doc_number] => 20210290570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => Pharmaceutical Composition for Preventing or Treating Cancer, Comprising Gossypol, Phenformin, and Anticancer Agent
[patent_app_type] => utility
[patent_app_number] => 17/259013
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259013 | Pharmaceutical composition for preventing or treating cancer, comprising gossypol, phenformin, and anticancer agent | May 16, 2019 | Issued |
Array
(
[id] => 20226300
[patent_doc_number] => 12414940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Method of treating malignant tumor by azabicyclic compound
[patent_app_type] => utility
[patent_app_number] => 17/055446
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 1895
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055446 | Method of treating malignant tumor by azabicyclic compound | May 13, 2019 | Issued |
Array
(
[id] => 15708553
[patent_doc_number] => 20200101042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => 4-METHYLUMBELLIFERONE TREATMENT FOR IMMUNE MODULATION
[patent_app_type] => utility
[patent_app_number] => 16/403293
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16403293
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/403293 | 4-METHYLUMBELLIFERONE TREATMENT FOR IMMUNE MODULATION | May 2, 2019 | Abandoned |
Array
(
[id] => 19380915
[patent_doc_number] => 20240270785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => NOVEL MOGROSIDES, METHODS OF OBTAINING THE SAME, AND USES
[patent_app_type] => utility
[patent_app_number] => 17/049646
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049646
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049646 | Mogrosides, methods of obtaining the same, and uses | Apr 22, 2019 | Issued |
Array
(
[id] => 17272895
[patent_doc_number] => 20210379093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => COMPOSITIONS OF O-GLYCOSYL FLAVONOIDS
[patent_app_type] => utility
[patent_app_number] => 16/497746
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497746 | Compositions of O-glycosyl flavonoids | Apr 22, 2019 | Issued |
Array
(
[id] => 19324853
[patent_doc_number] => 12042506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Prebiotic compositions and methods of production thereof
[patent_app_type] => utility
[patent_app_number] => 17/044946
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4768
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044946 | Prebiotic compositions and methods of production thereof | Apr 3, 2019 | Issued |
Array
(
[id] => 14622035
[patent_doc_number] => 20190224385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => CATHETER LOCK SOLUTION FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/373850
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373850
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/373850 | Catheter lock solution formulations | Apr 2, 2019 | Issued |
Array
(
[id] => 14621891
[patent_doc_number] => 20190224313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => Adjuvant System for Vaccine Administration
[patent_app_type] => utility
[patent_app_number] => 16/373132
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373132
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/373132 | Adjuvant System for Vaccine Administration | Apr 1, 2019 | Abandoned |
Array
(
[id] => 19763188
[patent_doc_number] => 12221461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Saponin adjuvant and evaluation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/041175
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5525
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041175
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041175 | Saponin adjuvant and evaluation method thereof | Mar 26, 2019 | Issued |
Array
(
[id] => 20534411
[patent_doc_number] => 12551462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Anti-aging composition with rutin, apigenin, epigallocatechin gallate, lipoic acid and the NAD precursor, niacinamide
[patent_app_type] => utility
[patent_app_number] => 16/980187
[patent_app_country] => US
[patent_app_date] => 2019-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2172
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980187
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980187 | Anti-aging composition with rutin, apigenin, epigallocatechin gallate, lipoic acid and the NAD precursor, niacinamide | Mar 12, 2019 | Issued |
Array
(
[id] => 16612123
[patent_doc_number] => 20210030776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => PARASITICIDAL COMPOSITIONS COMPRISING EPRINOMECTIN AND PRAZIQUANTEL, METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/966530
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966530
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966530 | Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof | Feb 6, 2019 | Issued |
Array
(
[id] => 14649193
[patent_doc_number] => 20190231725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => Compositions and Methods for Treatment of Diabetic Neuropathies
[patent_app_type] => utility
[patent_app_number] => 16/264614
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264614
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264614 | Compositions and methods for treatment of diabetic neuropathies | Jan 30, 2019 | Issued |